Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literature

2.50
Hdl Handle:
http://hdl.handle.net/10033/620955
Title:
Corticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literature
Authors:
Möller, Jana C; Cron, Randy Q; Young, Daniel W; Girschick, Hermann J; Levy, Deborah M; Sherry, David D; Kukita, Akiko; Saijo, Kaoru; Pessler, Frank
Abstract:
Abstract Spinal epidural lipomatosis is a rare complication of chronic corticosteroid treatment. We report a new pediatric case and an analysis of this and 19 pediatric cases identified in the international literature. The youngest of these combined 20 patients was 5 years old when lipomatosis was diagnosed. Lipomatosis manifested after a mean of 1.3 (+/- 1.5) years (SD) (median, 0.8 years; range, 3 weeks - 6.5 years) of corticosteroid treatment. The corticosteroid dose at the time of presentation of the lipomatosis ranged widely, between 5 and 80 mg of prednisone/day. Back pain was the most common presenting symptom. Imaging revealed that lipomatosis almost always involved the thoracic spine, extending into the lumbosacral region in a subset of patients. Predominantly lumbosacral involvement was documented in only two cases. Although a neurological deficit at presentation was documented in about half of the cases, surgical decompression was not performed in the cases reported after 1996. Instead, reducing the corticosteroid dose (sometimes combined with dietary restriction to mobilize fat) sufficed to induce remission. In summary, pediatric spinal epidural lipomatosis remains a potentially serious untoward effect of corticosteroid treatment, which, if recognized in a timely manner, can have a good outcome with conservative treatment.
Citation:
Pediatric Rheumatology. 2011 Feb 01;9(1):5
Issue Date:
1-Feb-2011
URI:
http://dx.doi.org/10.1186/1546-0096-9-5; http://hdl.handle.net/10033/620955
Type:
Journal Article
Appears in Collections:
publications of the research group biomarker in infection and immunity [[TC] BIOM)

Full metadata record

DC FieldValue Language
dc.contributor.authorMöller, Jana Cen
dc.contributor.authorCron, Randy Qen
dc.contributor.authorYoung, Daniel Wen
dc.contributor.authorGirschick, Hermann Jen
dc.contributor.authorLevy, Deborah Men
dc.contributor.authorSherry, David Den
dc.contributor.authorKukita, Akikoen
dc.contributor.authorSaijo, Kaoruen
dc.contributor.authorPessler, Franken
dc.date.accessioned2017-06-16T08:07:40Z-
dc.date.available2017-06-16T08:07:40Z-
dc.date.issued2011-02-01en
dc.identifier.citationPediatric Rheumatology. 2011 Feb 01;9(1):5en
dc.identifier.urihttp://dx.doi.org/10.1186/1546-0096-9-5en
dc.identifier.urihttp://hdl.handle.net/10033/620955-
dc.description.abstractAbstract Spinal epidural lipomatosis is a rare complication of chronic corticosteroid treatment. We report a new pediatric case and an analysis of this and 19 pediatric cases identified in the international literature. The youngest of these combined 20 patients was 5 years old when lipomatosis was diagnosed. Lipomatosis manifested after a mean of 1.3 (+/- 1.5) years (SD) (median, 0.8 years; range, 3 weeks - 6.5 years) of corticosteroid treatment. The corticosteroid dose at the time of presentation of the lipomatosis ranged widely, between 5 and 80 mg of prednisone/day. Back pain was the most common presenting symptom. Imaging revealed that lipomatosis almost always involved the thoracic spine, extending into the lumbosacral region in a subset of patients. Predominantly lumbosacral involvement was documented in only two cases. Although a neurological deficit at presentation was documented in about half of the cases, surgical decompression was not performed in the cases reported after 1996. Instead, reducing the corticosteroid dose (sometimes combined with dietary restriction to mobilize fat) sufficed to induce remission. In summary, pediatric spinal epidural lipomatosis remains a potentially serious untoward effect of corticosteroid treatment, which, if recognized in a timely manner, can have a good outcome with conservative treatment.en
dc.titleCorticosteroid-induced spinal epidural lipomatosis in the pediatric age group: report of a new case and updated analysis of the literatureen
dc.typeJournal Articleen
dc.language.rfc3066enen
dc.rights.holderMöller et al; licensee BioMed Central Ltd.en
dc.date.updated2015-09-04T08:24:15Zen
All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.